To combat the threat to human health and biosecurity from antimicrobial resistance, an
understanding of its mechanisms and drivers is needed. Emergence of antimicrobial resistance in …

Visceral leishmaniasis is common in less developed countries, with an estimated 500 000
new cases each year. Because of the diversity of epidemiological situations, no single …

Rolling back malaria is possible. Tools are available but they are not used. Several countries
deploy, as their national malaria control treatment policy, drugs that are no longer effective. …

Background Artemisinin resistance in Plasmodium falciparum has emerged in Southeast Asia
and now poses a threat to the control and elimination of malaria. Mapping the geographic …

Background The recording of outcomes from large-scale, simplified HAART (highly active
antiretroviral therapy) programmes in sub-Saharan Africa is critical. We aimed to assess the …

Although vaccination has almost eliminated measles in parts of the world, the disease
remains a major killer in some high birth rate countries of the Sahel. On the basis of measles …

Background A significant reduction in parasite clearance rates following artesunate treatment
of falciparum malaria, and increased failure rates following artemisinin combination …

Since the 1970s, when Chinese researchers demonstrated the artemisinins' antimalarial
potency, artemisinin-based combination therapy has become key to malaria control. But …

Background New-generation, orally administered cholera vaccines offer the promise of
improved control of cholera in sub-Saharan Africa. However, the high prevalence of human …

The state of Bihar in India carries the largest share of the world's burden of antimony-resistant
visceral leishmaniasis. We analysed clinical studies done in Bihar with different treatments …